VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P.VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P.

Institutional investor · Portfolio as of Q1 2019

Top Holdings183 positions

Checking export access…
Activity:

Roper Technologies Inc

447,495$153M2.1%$328.470.00%
1 qtr
First report
0

Kosmos Energy Ltd

24.4M$151.7M2.0%$5.990.00%
1 qtr
First report
0

NEXSTAR MEDIA GROUP INC-CLASS A

1.4M$149.5M2.0%$88.530.00%
1 qtr
First report
0
EAEADelisted

Electronic Arts Inc

1.5M$149.3M2.0%$98.810.00%
1 qtr
First report
0
RITMRITM
REIT

New Residential Investment Cor

8.3M$140M1.9%$8.630.00%
1 qtr
First report
0

CACI INTERNATIONAL INC CL A

748,350$136.2M1.8%$182.020.00%
1 qtr
First report
0

Microsoft Corp

1.1M$133.5M1.8%$110.120.00%
1 qtr
First report
0

AT&T Inc

4.1M$128.1M1.7%$14.440.00%
1 qtr
First report
0

Home Depot Inc/The

666,825$128M1.7%$159.310.00%
1 qtr
First report
0

Sherwin-Williams Co/The

290,656$125.2M1.7%$134.250.00%
1 qtr
First report
0

Berkshire Hathaway Inc

621,387$124.8M1.7%$200.890.00%
1 qtr
First report
0

Brink's Co/The

1.6M$121.3M1.6%$69.820.00%
1 qtr
First report
0

Walt Disney Co/The

1M$112.1M1.5%$107.170.00%
1 qtr
First report
0

Booz Allen Hamilton Holding Co

1.8M$107.3M1.4%$51.430.00%
1 qtr
First report
0

Dollar Tree Inc

985,080$103.5M1.4%$105.040.00%
1 qtr
First report
0

UnitedHealth Group Inc

400,029$98.9M1.3%$217.040.00%
1 qtr
First report
0

Cameco Corp

7.8M$91.4M1.2%$11.500.00%
1 qtr
First report
0

AbbVie Inc

1.1M$86.7M1.2%$58.820.00%
1 qtr
First report
0

Thermo Fisher Scientific Inc

316,399$86.6M1.2%$268.990.00%
1 qtr
First report
0

The Charles Schwab Corp

1.8M$77.3M1.0%$38.470.00%
1 qtr
First report
0
$7.5B
AUM
183
Positions
Q1 2019
Filing
HI score · 2.5/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
Q1'19

First report: nothing earlier to compare

Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
<1Q100%1-4Q0%1-2Y0%2Y+0%

VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. manages $7.5B across 183 positions as of Q1 2019. Top holdings: ROP (2.1%), KOS (2.0%), NXST (2.0%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 2.5/5.0.

Q1 2019 Summary

First quarter we have for this fund: 183 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $7.5B across 183 positions.

Top holdings by portfolio weight

Total AUM$7B
ROP2.05%
KOS2.03%
NXST2.01%
EA2.00%
RITM1.88%
CACI1.83%
MSFT1.79%
T1.72%
HD1.72%
SHW1.68%
Other1.67%

Portfolio allocation by GICS sector

Sectors11
Financial Services19.58%
Technology12.66%
Industrials12.15%
Unknown10.35%
Healthcare9.63%
Communication Services8.22%
Utilities5.48%
Consumer Cyclical5.24%
Energy4.87%
Consumer Defensive4.43%
Other7.38%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Financial Services, Technology, Industrials
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L67
Conviction40
Concentration30
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
6Q
GATXGATXGATX CORP
Q1 2025 → Q2 2026+378,015 shares+$72.9M
6Q
MELIMELIMercadolibre Inc
Q1 2025 → Q2 2026+8,279 shares+$14M
4Q
LNTLNTALLIANT ENERGY CORP
Q3 2025 → Q2 2026+486,390 shares+$46.8M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used